N-(3-Acetylphenyl)-2,4-dichlorobenzamide

Catalog No.: 
ACFQYO004
CAS No.: 
316143-07-4
Molecular Formula: 
C15H11Cl2NO2
Molecular Weight: 
308.16
N-(3-Acetylphenyl)-2,4-dichlorobenzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$176.00InquiryInquiry
1g95%$410.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(3-Acetylphenyl)-2,4-dichlorobenzamide
IUPAC NameN-(3-acetylphenyl)-2,4-dichlorobenzamide
MDL No.MFCD00422205
Molecular FormulaC15H11Cl2NO2
Molecular Weight308.16
SMILESO=C(NC1=CC=CC(C(C)=O)=C1)C2=CC=C(Cl)C=C2Cl
InChI KeyWYENSOXGXSFVCY-UHFFFAOYSA-N
SynonymN-(3-Acetylphenyl)-2,4-dichlorobenzamide;2,4-dichloro-N-(3-ethanoylphenyl)benzamide;IVK/8154131;ZINC00112646;Benzamide, N-(3-acetylphenyl)-2,4-dichloro-
CAS No.316143-07-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACFQYO004 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLRNS458 route compound structure diagram
    ACLRNS45899-03-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFQYO004 route product structure diagram
    ACFQYO004316143-07-4
Inquiry

2. ACFQYO004 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLRNS458 route compound structure diagram
    ACLRNS45899-03-6In Stock
  2. Plus
  3. ACETDQ076 route compound structure diagram
    ACETDQ07650-84-0In Stock
  4. Then
  5. ACFQYO004 route product structure diagram
    ACFQYO004316143-07-4
Inquiry

3. ACFQYO004 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFQYO004 route product structure diagram
    ACFQYO004316143-07-4
Inquiry

Comments (0)